A study published in the International Journal of Gynecology & Obstetrics examined the quality of mifepristone and misoprostol, two medications commonly used for medical abortions, in 11 countries. The study found that there were excess levels of impurities in both medications in eight of the countries. The impact of these impurities on safety and efficacy is not well understood. The study also identified a falsified version of the medication Cytotec®, which lacked any active ingredient. The presence of impurities in these medications could reduce their effectiveness and potentially cause harm to users. The study emphasizes the need for improved regulations and quality assurance standards for medical abortion medications to ensure the safety and efficacy of these drugs. [Extracted from the article]